News

NATURAL KILLER (NK) CELL THERAPEUTICS MARKET GROWTH BY 2026 | KIADIS PHARMA, PHIO PHARMACEUTICALS CORPORATION, GLYCOSTEM, EMERCELL, BRINK BIOLOGICS, INC., INNATE PHARMA

This Natural Killer (NK) Cell Therapeutics Market analysis report evaluates the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis. Integrated approaches and latest technology have been exploited for the best results while generating this report. Key elements covered in this business report are industry outlook along with critical success factors, industry dynamics, market definition, drivers and restraints, market segmentation, value chain analysis, key developments, application and technology outlook, regional or country level analysis and competitive landscape.

Get Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Few of the major competitors currently working in global natural killer (NK) cell therapeutics market are: Kiadis Pharma, Phio Pharmaceuticals Corporation, Glycostem, EMERCell, Brink Biologics, Inc., Innate Pharma, Sanofi, Nkarta, Inc., Affimed GmbH, CELGENE CORPORATION, Fate Therapeutics, Fortress Biotech, NKT Therapeutics , NantKwest, Sorrento Therapeutics, Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Altor BioScience, Regeneron Pharmaceuticals, Inc., Ziopharm Oncology, Inc. among others.

Key Developments in the Market:

  • In April 2019, Kiadis Pharma announced the acquisition of CytoSen Therapeutics, Inc. to acquire the natural killer (NK)-Cell platform established by CytoSen. This acquisition includes CytoSen’s CSTD002-NK, an NK-Cell therapy being developed for treatment of patients with acute myeloid leukemia. Kiadis will used the NK-Cell platform of CytoSen and develop a unique combination of NK-Cell and T-Cell platform
  • In March 2019, Phio Therapeutics Corp. and Glycostem announced research collaboration for development of a combination of sd-rxRNA, Phio’s RNAi technology and oNKord, Glycostem’s NK-Cell generation thechnology for the treatment of cancer. This collaboration will develop an improved cellular immunotherapy by incorporation of sd-rxRNA in NK-Cells for cancer treatment

Global Natural Killer (NK) Cell Therapeutics Market By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies, Others), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Reasons to Purchase this Report

  • Current and future of global natural killer (NK) cell therapeutics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Market Analysis: 

Global natural killer (NK) cell therapeutics market is rising gradually with a healthy CAGR of 17.4% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. Growing awareness about NK cells in treatment of cancer and infectious diseases are major drivers for market growth.

View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Market Definition: 

Natural killer cells (NK cells) are a type of lymphocyte (a white blood cell) responsible for killing virally infected cells and they are responsible for production of immune regulatory cytokines. These are components of the innate immune system. NK cells detect and controls the tumor cells in the body. NK cells therapeutics is applied in detection, treatment and management of various diseases such as cancer, gastrointestinal diseases and infectious diseases.

According to an article published in the National Center for Biotechnology Information, about 3-5% of human peripheral blood lymphocytes are NK cells. The emerging NK cell therapeutics is basically developed to target the cancer cells by controlling the various mechanisms of NK cells such as cytotoxicity.

Market Drivers

  • Increasing adoption of NK cells for cancer and infectious diseases treatment will increase the market size
  • Growing research and development of NK cells to target tumor cells acts as driver for the market growth
  • Increasing healthcare expenditure by government in development of immunotherapies is expected to fuel the growth of the market
  • Rising prevalence of cancer incidence across the globe is escalating the market in the forecast period

Market Restraints

  • Lack of specific treatment by NK cells and poor in-vivo survival of the cells obstructs the market growth
  • High cost associated with the therapies hampers the growth of the market in the forecast period
  • Adverse side effects of the therapies will hinder the growth of the market
  • Stringent regulatory policies for approval of immunotherapy challenges the market growth

Segmentation: 

By Therapeutics

  • NK Cell Therapies
  • NK Cell Directed Antibodies
  • Others

By Application

  • Cancer
  • Gastrointestinal Diseases
  • Immunoproliferative Disorders
  • Others

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channels

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

Order a Copy of Global Natural Killer (NK) Cell Therapeutics Market Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-natural-killer-nk-cell-therapeutics-market